Prospective Cohort Study of 4,837 Post-myocardial Infarction Patients (Alpha Omega Cohort)
NCT03192410 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4837
Last updated 2017-06-20
Summary
The Alpha Omega Cohort is a prospective study of 4,837 state-of-the-art drug-treated Dutch patients aged 60-80 years who had a clinically diagnosed myocardial infarction up to 10 years before enrolment. During the first 40 months of follow-up, patients took part in an experimental study of low doses n-3 fatty acids (Alpha Omega Trial, ClinicalTrials.gov NCT00127452). At baseline (2002-2006), data on medical history, medication use, diet, lifestyle and other factors were collected by means of questionnaires. Patients were physically examined by trained research nurses and blood samples were obtained. Follow-up for vital status and cause-specific mortality is ongoing. The trial was approved by a central medical ethics committee (Haga Hospital, The Hague, The Netherlands) and all patients provided written informed consent.
Conditions
- Cardiovascular Diseases
- Mortality
- Type 2 Diabetes Mellitus
- Cognitive Decline
- Mental Well-being
- Kidney Function
Interventions
- BEHAVIORAL
-
Dietary intake
Intake of nutrients, foods, food groups, beverages; dietary patterns.
- BEHAVIORAL
-
Lifestyle factors
Physical activity; smoking; alcohol use; educational level.
- BIOLOGICAL
-
Blood biomarkers
Biomarkers of dietary intake (e.g. fatty acids); biomarkers of disease.
- BIOLOGICAL
-
Health
Current health status; medical history; medication use; self-rated health; risk factors for disease (e.g. body mass index, blood pressure, blood lipids, glucose)
- GENETIC
-
DNA
SNPs (GWAS)
- BIOLOGICAL
-
Mental well-being
Cognitive function; dispositional optimism; depression.
Sponsors & Collaborators
-
Wageningen University
lead OTHER
Principal Investigators
-
Johanna M Geleijnse, PhD · Wageningen University, Division of Human Nutrition
Eligibility
- Min Age
- 60 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Primary Completion
- 2040-01-31
- Completion
- 2040-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation
NCT01235130 ·Status: COMPLETED ·Phase: PHASE3
-
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217 ·Status: COMPLETED ·Phase: NA
-
Fatty Acid Metabolism in Carriers of Apolipoprotein E Epsilon 4 Allele: Determining the Blood-to-brain Link
NCT04279743 ·Status: UNKNOWN ·Phase: NA
-
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
NCT01422317 ·Status: COMPLETED ·Phase: PHASE3
-
Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?
NCT01699230 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
Intervention With Omega Fatty Acids in High-risk Patients
NCT02647333 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3D: Omega-3 for Diet-Driven Health Disparities
NCT07078344 ·Status: RECRUITING ·Phase: PHASE2
-
Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.
NCT02178501 ·Status: COMPLETED ·Phase: NA
-
Intervention With Vitamin D and Omega-3 Supplements and Incident Heart Failure
NCT02271230 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Relationship Between Fatty Acids and Heart Disease
NCT00404872 ·Status: COMPLETED
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
NCT00729430 ·Status: COMPLETED ·Phase: PHASE3
-
Diet and Omega-3 Intervention Trial on Atherosclerosis
NCT00764010 ·Status: COMPLETED ·Phase: PHASE3
-
Heart & Health Study
NCT00536185 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Supplementation on Serum Fetuin-A Levels
NCT05661994 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
NCT00663871 ·Status: COMPLETED ·Phase: NA
-
The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.
NCT04743050 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation
NCT01310270 ·Status: COMPLETED ·Phase: NA
-
Alpha and Omega of Lifestyle Therapy
NCT04279951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
NCT00116857 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Omega-3 Fatty Acid on Endothelial Function
NCT01813006 ·Status: COMPLETED ·Phase: PHASE3
-
Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins
NCT00976872 ·Status: COMPLETED ·Phase: NA
-
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
NCT00504309 ·Status: COMPLETED ·Phase: NA